Intuitive Surgical's NASDAQ: ISRG primary headwinds are its high valuation and slowing growth. The combination has weighed on price action since early 2025 and is unlikely to go away soon.

The Biggest Takeaway From ISRG Earnings

09:40am, Thursday, 23'rd Apr 2026
The key takeaway from Intuitive Surgical's (ISRG) Q1 2026 results is the implementation of a fundamental “Platform Refresh Wall.” In addition to the $2.50 EPS exceeding expectations and a revenue
Caprock Group LLC boosted its stake in Intuitive Surgical, Inc. (NASDAQ: ISRG) by 23.5% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commi
B. Metzler seel. Sohn and Co. AG lessened its holdings in Intuitive Surgical, Inc. (NASDAQ: ISRG) by 8.7% during the fourth quarter, according to the company in its most recent disclosure with the SEC
These companies offer a clear path to sustained earnings growth.
Intuitive Surgical is upgraded to a 'cautious buy' despite a premium valuation, reflecting its monopoly position and robust long-term growth prospects. ISRG delivered a strong Q1 with 23% YoY revenue
Intuitive Surgical demonstrated robust Q1 adoption metrics, accelerating revenue growth, and expanding margins, reinforcing the long-term growth thesis. ISRG raised its full-year outlook for da Vinci
The robots aren't coming in the healthcare sector; they are already here, and Intuitive Surgical sells them.
UnitedHealth's turnaround efforts are gaining traction, while Intuitive Surgical continues to benefit from long-term global adoption of robotic-assisted surgery.
The surgical robotics company's latest quarterly report was exceptional across the board.
Intuitive Surgical delivered strong Q1 results, with 23% revenue growth, margin expansion, and EPS beating estimates by $0.39. ISRG raised its procedure growth guidance to 13.5%-15.5% and gross margin
Intuitive Surgical Inc (NASDAQ:ISRG, XETRA:IUI1) reported stronger-than-expected quarterly results, supported by continued adoption of its robotic-assisted surgical platforms and solid procedural gro
ISRG jumps after Q1 EPS and revenues beat estimates as da Vinci and Ion procedure growth powers recurring sales and da Vinci 5 placements.
Intuitive Surgical (ISRG) climbed about 7% on Wednesday after the maker of da Vinci robot-assisted surgical systems lifted its 2026 outlook and posted first-qua
Intuitive Surgical Inc (NASDAQ:ISRG) reported upbeat financial results for the first quarter of 2026 after the market close on Tuesday.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE